Study 12 of 107 for search of: "Varicella"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-Infected Patients
This study has been completed.
Sponsored by: GlaxoSmithKline
Information provided by: GlaxoSmithKline
ClinicalTrials.gov Identifier: NCT00127608
  Purpose

This study is conducted in order to collect clinical samples from patients who are diagnosed of having chickenpox infection. The results of this study will provide basic scientific information about chickenpox disease.


Condition Intervention Phase
Chickenpox
Biological: Chickenpox infection
Phase III

MedlinePlus related topics: Chickenpox Shingles
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Single Group Assignment
Official Title: An Open, Prospective, Non-Prophylactic, Non Therapeutic Study for the Detection and Characterisation of Varicella Zoster Virus Collected From Dermal Lesions of Patients Who Are Diagnosed of Having Varicella

Further study details as provided by GlaxoSmithKline:

Primary Outcome Measures:
  • VZV DNA per clinical sample collected

Study Start Date: June 2005
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Detailed Description:

The study involves NO therapeutic or prophylactic treatment nor further observation of the patients. There is no product to be tested in this study.

  Eligibility

Ages Eligible for Study:   up to 16 Years
Genders Eligible for Study:   Both
Criteria

Pediatric patients who are diagnosed of having varicella and are presenting varicella dermal lesions.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00127608

Locations
Czech Republic
GSK Investigational Site
Praha 8, Czech Republic, 180 81
Sponsors and Collaborators
GlaxoSmithKline
Investigators
Study Director: GSK Clinical Trials GlaxoSmithKline
  More Information

Responsible Party: GSK ( Study Director )
Study ID Numbers: 103815
Study First Received: August 4, 2005
Last Updated: October 9, 2008
ClinicalTrials.gov Identifier: NCT00127608  
Health Authority: Czech Republic: State Institute for Drug Control

Study placed in the following topic categories:
Virus Diseases
Herpes Zoster
Chickenpox
DNA Virus Infections
Chicken pox
Varicella Zoster
Herpesviridae Infections

ClinicalTrials.gov processed this record on January 14, 2009